| Revenue | NOK 0 | — |
| EBITDA | NOK -59K | -40% |
| Net profit | NOK -76K | -29% |
| Total assets | NOK 121K | -11% |
| Equity | NOK 11K | -88% |
| Employees | 0 | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 56 | 63 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | 0 | −13 | −73 | 38 | −15 | −42 | −59 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −9 | −16 | −17 | −17 |
| EBIT | −6 | 0 | −13 | −73 | 29 | −31 | −59 | −76 |
| Net financials | 0 | −0 | −0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −6 | −0 | −14 | −73 | 29 | −31 | −59 | −76 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 | −0 | −14 | −73 | 29 | −31 | −59 | −76 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 24 | 24 | 71 | 71 | 194 | 193 | 136 | 121 |
| Equity | 24 | 24 | 10 | −63 | 177 | 145 | 86 | 11 |
| Long-term debt | 0 | 0 | 61 | 60 | 0 | 48 | 48 | 98 |
| Short-term debt | 0 | 0 | 0 | 73 | 17 | 0 | 2 | 12 |
| Total debt | 0 | 0 | 61 | 133 | 17 | 48 | 50 | 111 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ET Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Wike Helse As | Company | 26.8% | 26.8% | 2022 |
Kongsberg Innovasjon As | Company | 25.0% | 25.0% | 2022 |
Healthinvest As | Company | 10.6% | 10.6% | 2022 |
Drammen Sportsklinikk As | Company | 9.0% | 9.0% | 2022 |
| Person | Role here | Other companies |
|---|---|---|
| Egil Trømborg | Chief Executive Officer | 0 companies |
| Svein Olav Torø | Board of Directors | 0 companies |
| Tom Arild Wike | Chairman | 0 companies |